Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Improved Survival of Stage I Non–Small Cell Lung Cancer: A VA Central Cancer Registry Analysis
Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H. Harpole, MD, Mark W. Onaitis, MD, Michael J. Kelley, MD, Joseph K. Salama, MD Journal of Thoracic Oncology Volume 12, Issue 12, Pages (December 2017) DOI: /j.jtho Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Improvement in survival of the radiation cohort with stereotactic body radiation therapy (SBRT) versus with conventionally fractionated radiation (CRT). (A) Four-year OS by year of diagnosis for patients treated with surgery, radiation, or no treatment. Data are mean plus or minus SE. (B) Proportion of patients treated with radiation who underwent CRT and SBRT, by year of diagnosis. (C) Overall survival of all patients undergoing either CRT or SBRT. (D) Lung cancer–specific survival of all patients undergoing either CRT or SBRT. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Trends in utilization of surgical modalities and associated survival. (A) Proportion of surgical patients undergoing each procedure by the year of diagnosis. (B) Overall survival of surgical patients by modality. (C) Lung cancer–specific survival of surgical patients by modality. (D) Overall status of propensity score–matched surgical patients undergoing video-assisted thoracoscopic surgical (VATS) or open lobectomy. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Survival after lobectomy is improved over that after sublobar resection for medically fit patients. (A) Overall survival (OS) of propensity score–matched surgical patients undergoing lobectomy or sublobar resection by either a video-assisted thoracoscopic surgical (VATS) or open procedure. (B) Four-year OS after lobectomy or sublobar resection, either VATS or open, for patients with a CCI of 0 or 1. Data are mean plus or minus SE. (C) Four-year OS after lobectomy or sublobar resection, either VATS or open, for patients with a CCI of 2. Data are mean plus or minus SE. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 Survival after lobectomy is superior to stereotactic body radiation therapy (SBRT). (A) Overall survival of all patients undergoing surgery, radiation, or no treatment. (B) Lung cancer–specific survival of all patients undergoing surgery, radiation, or no treatment. (C) Overall survival of propensity score–matched patients treated by either lobectomy or SBRT. (D) Lung cancer–specific survival of propensity score–matched patients treated by either lobectomy or SBRT. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Tables 1 and 2
Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure 2A

Supplementary Figure 2B

Supplementary Figure 3C

Supplementary Figure 3D

Supplementary Figure 5C

Supplementary Figure 5D

Supplementary Figure 5E

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Similar presentations

Presentation on theme: "Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H"— Presentation transcript:

Similar presentations

About project

Feedback

Log in

Auth with social network:

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Similar presentations

Presentation on theme: "Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H"— Presentation transcript:

Similar presentations

About project

Feedback